Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Convalescent Plasma for the Treatment of Moderate-severe COVID-19: A Proof-of-principle Study

NCT04365439 is registered in ClinicalTrials.gov with Enos Bernasconi as lead sponsor.

NCT NCT04365439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04365439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Convalescent Plasma for the Treatment of Moderate-severe COVID-19: A Proof-of-principle Study
Lead sponsor
Enos Bernasconi
Phase
Not applicable
Overall status
Unknown status
Start date
July 20, 2020
Completion date
June 30, 2021
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood plasma therapy, covid